These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Radiochemical high-performance liquid chromatography detection of arginine metabolism in human endothelial cells. Barilli A; Visigalli R; Rotoli BM; Bussolati O; Gazzola GC; Parolari A; Dall'Asta V Anal Biochem; 2012 May; 424(2):156-61. PubMed ID: 22381370 [TBL] [Abstract][Full Text] [Related]
3. Arginase as a potential target in the treatment of cardiovascular disease: reversal of arginine steal? Pernow J; Jung C Cardiovasc Res; 2013 Jun; 98(3):334-43. PubMed ID: 23417041 [TBL] [Abstract][Full Text] [Related]
4. Endothelial arginase II: a novel target for the treatment of atherosclerosis. Ryoo S; Gupta G; Benjo A; Lim HK; Camara A; Sikka G; Lim HK; Sohi J; Santhanam L; Soucy K; Tuday E; Baraban E; Ilies M; Gerstenblith G; Nyhan D; Shoukas A; Christianson DW; Alp NJ; Champion HC; Huso D; Berkowitz DE Circ Res; 2008 Apr; 102(8):923-32. PubMed ID: 18309100 [TBL] [Abstract][Full Text] [Related]
5. Arginase: a critical regulator of nitric oxide synthesis and vascular function. Durante W; Johnson FK; Johnson RA Clin Exp Pharmacol Physiol; 2007 Sep; 34(9):906-11. PubMed ID: 17645639 [TBL] [Abstract][Full Text] [Related]
6. The Mechanisms of L-Arginine Metabolism Disorder in Endothelial Cells. Mammedova JT; Sokolov AV; Freidlin IS; Starikova EA Biochemistry (Mosc); 2021 Feb; 86(2):146-155. PubMed ID: 33832413 [TBL] [Abstract][Full Text] [Related]
7. Roads to dysfunction: argininase II contributes to oxidized low-density lipoprotein-induced attenuation of endothelial NO production. Brandes RP Circ Res; 2006 Oct; 99(9):918-20. PubMed ID: 17068298 [No Abstract] [Full Text] [Related]
8. Arginase as a Critical Prooxidant Mediator in the Binomial Endothelial Dysfunction-Atherosclerosis. Rabelo LA; Ferreira FO; Nunes-Souza V; da Fonseca LJ; Goulart MO Oxid Med Cell Longev; 2015; 2015():924860. PubMed ID: 26064427 [TBL] [Abstract][Full Text] [Related]
9. Biochemical characterization of the arginine degrading enzymes arginase and arginine deiminase and their effect on nitric oxide production. Sezgin N; Torun T; Yalcin F Med Sci Monit; 2002 Oct; 8(10):LE44. PubMed ID: 12434793 [No Abstract] [Full Text] [Related]
10. Treatment with the arginase inhibitor N(omega)-hydroxy-nor-L-arginine improves vascular function and lowers blood pressure in adult spontaneously hypertensive rat. Bagnost T; Berthelot A; Bouhaddi M; Laurant P; André C; Guillaume Y; Demougeot C J Hypertens; 2008 Jun; 26(6):1110-8. PubMed ID: 18475148 [TBL] [Abstract][Full Text] [Related]
11. Radiochemical HPLC detection of arginine metabolism: measurement of nitric oxide synthesis and arginase activity in vascular tissue. de Bono JP; Warrick N; Bendall JK; Channon KM; Alp NJ Nitric Oxide; 2007 Feb; 16(1):1-9. PubMed ID: 16647284 [TBL] [Abstract][Full Text] [Related]
12. Cellular and molecular mechanisms of endothelial cell dysfunction. Harrison DG J Clin Invest; 1997 Nov; 100(9):2153-7. PubMed ID: 9410891 [No Abstract] [Full Text] [Related]
13. The role of arginine-nitric oxide pathway in patients with Alzheimer disease. Vural H; Sirin B; Yilmaz N; Eren I; Delibas N Biol Trace Elem Res; 2009; 129(1-3):58-64. PubMed ID: 19099206 [TBL] [Abstract][Full Text] [Related]